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T lymphocytes are originally derived from the pluripotential stem cell, as are
all hematopoiesic cells . The source of precursor T lymphocytes is generally
thought to be the bone marrow (apart from the transient hematopoiesis in the
fetal liver), from where they migrate to the thymic cortex to initiate T cell
differentiation (1). With the advent of the methodology for production of mAbs
against T lymphocyte differentiation antigens (2), the unraveling of the T
lymphocyte receptor structure (3) and the intrathymic differentiation of T
lymphocytes has been elucidated in great detail . In contrast, much less is known
about the prethymicT lymphocyte, especially concerning its origin, cell renewal
capacity, and surface-marker phenotype . Even though there is ample evidence
fromT cell malignancies suggesting that the majority of these diseases represent
frozen stages of differentiation corresponding to different thymocyte subsets (4,
5), a minority of T cell acute lymphoblastic leukemia cells (T-ALLs) have been
found to express the common acute lymphoblastic leukemia (CALLA) antigen
(usually defined by mAbs belonging to Cluster of Differentiation (CD) 10 of the
Leucocyte Typing Workshops), which is not found in the fetal thymus (5, 6) .
Even though this antigen is widely distributed in different body tissues, it has
been found extremely useful in the differential diagnosis ofchildhood leukemias,
where it has been shown that patients expressing this antigen have a more
favorable prognosis within the non-T-ALL subset (7) .
We have recently developed a method for purifying a population ofimmature
lymphoid cells from fetal tissues, which express CALLA. Cells obtained by this
procedure are morphologically lymphoid and lack mature T cells and myeloid
markers . It is believed that these cells represent the normal cellular counterpart
of a neoplastic CALLA' pre-B cell seen in non-T-ALL (8). Furthermore, when
bulk cultures of such cells are stimulated with PMA or leukocyte-conditioned
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medium, an orderly expression of B cell antigens, including early changes in the
surface Ig isotypes, could be demonstrated (9).
Given the fact that not all of these immature lymphoid cells expressed the pan-
B antigen B4 (CD 19) (10), which is present on B-lymphoid cells at an even
earlier stage than CALLA (9), we hypothesized that within such early lymphoid
cells a CALLA' prethymic cell subset could well reside . Since phenotyping
experiments had failed to demonstrate known T cell antigens on these cells, we
opted to clone them in leucocyte-conditioned medium on selected feeder cells to
expand cells with potentials for T cell differentiation. Here we demonstrate that
such procedures indeed yielded T cell clones with a mature phenotype. More-
over, we could demonstrate that such cells had passed through a phase of
simultaneous expression of T4 or T8 antigens consistent with the already
established acquisition of T cell antigens during thymic differentiation.
Materials and Methods
Purification of Fetal Progenitor Cells from Fetal Bone Marrow.
￿
Single-cell suspensions
from fetal femoral bone marrows were incubated for 30 min at 4°C with a mixture of
mAbs reacting with erythroid and myeloid cells as well as mature T lymphocyte antigens:
anti-MY7 (CD 13), anti-MY8, anti-MY9, anti-Mol(CD 11), anti-T3(CD 3), anti-T9, and
anti-T 11(CD 2); for a more thorough description of the reactivities of these antibodies
see references 8 and 9. Labeled mononuclear cells were then rosetted with sheep
erythrocytes coated with rabbit anti-mouse Ig (kindly donated by J. D. Griffin, Harvard
Medical School) by the chromium-chloride method (8). After centrifugation on Ficoll-
Hypaque gradients, nonrosetted cells, depleted of erythroid, myeloid cells, as well as
mature T cells, were harvested, counted, and analyzed for surface antigens in a standard
two-layer immunofluorescence assay. Single-cell suspensions were also prepared from fetal
liver and fetal thymus by standard procedures and adult monocytes were prepared from
peripheral blood mononuclear cells after plastic adherence for 45 min at 37 °C.
Cloning of CALLA+ Fetal Progenitor Cells.
￿
Nonrosetted cells prepared as described
above were labeled with anti-CALLA J5(CD 10) antibodies and FITC-goat anti-mouse
antibodies (G/M-FITC). Using the autocloning unit of an Epics V (Coulter Electronics,
Hialeah, FL) cell sorter, CALLA+ cells were delivered into round-bottomed, 96-well
°fnicrotiter plates (Costar, Cambridge, MA) containing 2.5 x 104 feeder cells in 200 ul
culture medium (RPMI 1640 supplemented with 10% FCS, Hepes, antibiotics, and 10%
leucocyte-conditioned medium prepared as described in reference 11). As often as
possible, each combination of CALLA+ cells and feeder cells were set up in triplicate in
concentrations of CALLA+ cells ranging from 1 to 20.
Double-Marker Analysis of Outgrowing Clones.
￿
In three separate experiments the micro-
titer plates containing the CALLA+ cells were washed once and all wells were labeled with
directly fluoresceinated anti-T4 antibodies (Coulter Immunology), followed by the T8
antibodies labeled with rhodamine, followed by Texas red-avidin. In separate experiments
cells were labeled with anti-T6 followed by fluoresceinated goat anti-mouse antibodies
and T8-rhodamine followed by Texas red-avidin.
Besides the above phenotyping, which was performed 10 d before macroscopic growth
could be observed, phenotyping was also performed after visual growth was observed
(usually 17-21 d after setup) on clones that had been expanded separately in 24-well flat-
bottomed tissue culture plates (Costar). Such cells were labeled in standard two-layer
immunofluorescence assays and analyzed by cell cytometry in a FACS 1 (Becton Dickinson
Immunocytometry Systems, Mountain View, CA). The number of cells reactive with a
given antibody was calculated after subtracting the reactivity with ascites from a nonpro-
ducing hybridoma.HOKLAND ET AL .
￿
BRIEF DEFINITIVE REPORT
TABLE I
Effect ofDifferentFeeder Cells on Proliferation ofPurified Calla'
Fetal Bone Marrow Cells
Feeder cells*
* 2 .5 X 10' cells per well ; as wells contained 10% LCM in complete culture medium .
BM, bone marrow ; MNC, mononuclear cells; Mo, monocytes.
* Added by flow cytometry autocloning. Phenotyping of presort BM cells: J5 : 87%,
81 % ; B4: 81%,73% ; T3,T4, T6, T8, and TI 1 : all<0 .1% . FART rosetting : <1 :10,000
rosette-forming cells . Phenotypic analysis of sorted cells subsequently allowed to
shed CALLA-G/M FITC conjugatesat 37 0C overnight :J5 : >98%, >98% ; B4 : 88%,
90% ; T3, T4, T6, T8, and T11 : all <0.1% . EAET rosetting: <1 :10,000 rosette-
forming cells .
Number of positive wells in two separate experiments .
TABLE II
Delivered using an EPICS-V flow cytometer . 2 .5 X 10' irradiated, autologous thymocytes in each
well . Precloning phenotypes : J5 : 80-92% . T3, T4, T6, T8 and Tl l : all <0.1% . EeeT rosetting:
<1 :10,000 rosette-forming cells.
* Phenotype of separate analyses of the involved antigens . Positive antigens were present on >90%
of the cells from each clone . Negative antigens were absent on >98% ofthe cells from each clone.
All clones were negative for CALLA (15) and positive for HLA-DR antigens . In no instances were
clones with other phenotypes observed .
Results and Discussion
175 1
To establish the experimental conditions suitable for expanding cloned
CALLA+ cells, we delivered one cell to each well in five different 96-well
microtiter plates containing different feeder cells using the autocloning accessory
of the Epics V cell sorter . As will be seen from Table 1, in two separate
experiments with five plates each, significant growth could be obtained only
from trays containing autologous and (in one experiment only) allogeneic,
irradiated (5,600 rad over 25 min) thymocytes .
>90% of such cultures could be expanded into 24-well microtiter plates
without feeder cells over 3-5 wk, and when they were subsequently phenotyped,
it was apparent that they were all (both autologous, as well as allogeneic thymo-
cytes as feeder cells) of clonal origin representing monomorphic populations of
mature T lymphocytes being entirely positive (>95% on all clones) for either the
T4(CD4) helper/inducer or the T8(CD8) cytotoxic/suppressor antigen (Table
II) . Further cell-surface marker analysis performed on these clones showed that
they were all positive forHLA-DR antigens and negative for the T6 andCALLA
Phenotyping ofClones Expanded from Wells
One CALLA+ Cell per Well
Containing
Exp. T3/T4/T11*, T8-* T3/T8/TI I+, T4-* T3/T4/T8/T11'*
1 3 3 0
2 9 5 0
3 7 6 0
4 4 8 0
5 4 6 0
Number
of cells Autologous Allogeneic
per well*
Liver MNC BM MNC Thymocytes Thymocytes Adult Mo
0 ND, ND1 0,0 0,0 0, ND 0,0
1 0,0 0,0 18,14 9, ND 0,0
5 0,0 0,0 17,19 13, ND 0,0
10 0,0 0,0 35,41 20, ND 0,01752 HOKLAND ET AL.
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TABLE III
Double-Marker Analysis on Day 10 of Viable Cellsfrom 96-Well
Microtiter Plates with One CALLA' Delivered to Each Well by
Flow Cytometry Autocloning
* Percentage double-marker-positive cells after counting at least 50 viable cells in
the fluorescence microscope.
antigens, corroborating the mature stage in Tcell differentiation of these cells.
No clones with other phenotypes (e.g., those of thymocytes, B cells, or myeloid
cells) were ever observed.
We believe that these experiments indicate that the cloned CALLA' cells
contained a prethymic T lymphocyte lacking known T cell markers. It can,
however, be argued that the cloned CALLA' cells might have contained
CALLA- immature Tcells, but for the following reasons we believe that this is
not the case: (a) Reanalysis of CALLA' cells sorted using standard procedures
in the FACS V contained >98% CALLA' cells; (b) even before enrichment for
CALLA in the Epics V, nonrosetted T3 and TI I depleted cells contained <1%
ofcells expressing these antigens, as well as T4 and T8; (c) EAET (erythrocytes
treated with S-(2-aminoethyl)-isothiouronium bromide) rosette formation on
nonimmune rosetted cells cultured overnight at 37°C never showed more than
0.1% EAE-r rosette-forming cells (RFC).
Given these considerations, gross T cell contamination in the sorted suspen-
sions can be safely ruled out, and since the mean percent of wells with growth in
five experiments was 1 I%, these data strongly suggest that the CALLA' cells
contained prethymic T cells. To further elucidate the pathway during which
these cells had differentiated we performed two-color fluorescence analysis in
the fluorescence microscope ofall wells ofmicrotiter plates, where one CALLA'
cell had been delivered to each well. This was done 10 d after initiation of
culture, at a point where no macroscopic growth could be seen, with the object
of evaluating the phenotypic markers of cells proliferating at this early time of
culture. As will be seen from Table 111, cells that expressed the T8 antigen
concomitantly with either T4 or T6 antigens could be demonstrated in three
separateexperiments. In control experiments with wells containing the irradiated
thymocytes alone, onlynonviable cells with no well-defined immunofluorescence
were seen, thus excluding the possibility that the above described fluorescence
was due to expansion of irradiation insensitive feeder cells. Thus, we have
demonstrated that in cultures containing purified CALLA' cells lacking T cell
markers such cells can be induced to differentiate to a stage of dual expression
ofT4/T8 or T6/T8 to a stage ofmature Tcell differentiation.
Recently, van Dongen et al. (12) showed the existence ofa terminal deoxynu-
cleotidyltransferase-positive (TdT') Tp41' precursor T cell in both adult and
childhood bone marrow samples in frequencies ofabout 5 in 10,000 mononuclear
cells. Even though we did not use TdT in this study, it is noteworthy that
CALLA' cells purified to homogeneity contained significant amounts (30-50%)
Exp.
T4-FITC/T8-
rhodamine-positive
Texas red-avidin
T6 + G/M-FITC/T8-
rhodamine-positive
Texas red-avidin
1 17* 14*
2 22 22
3 27 21HOKLAND ET AL.
￿
BRIEF DEFINITIVE REPORT
￿
1753
of TdT' cells (8). Furthermore, since the CALLA' constitute 1-3% of fetal
mononuclear bone marrow cells, and since 10% of such cells could be cloned,
the frequency of our precursor cells is similar to that of van Dongen et al. On
the other hand, our approach differs from theirs, since we have chosen to isolate
prethymic precursor cells from a pool ofcells entirely negative for T cell antigens .
Whether the success of cloning T cells from purified CALLA' cells indicates
that T cell antigens are acquired in the thymus by T cell antigen-negative cells
migrating from the bone marrow cannot be determined, and it is entirely possible
that different pathways for prethymic T cells exist involving both the ones
described by van Dongen et al . and the one described in this paper.
Summary
We have cloned common acute lymphoblastic leukemia (CALLA)-positive
cells from human fetal bone marrow containing <1 in 10,000 E-RFC in round-
bottomed microtiter wells (one cell per well) using the autocloning unit of an
EPICS-V cell sorter. Expansion of such cells (with IL-2 and heavily irradiated
autologous thymocytes as feeder cells) resulted in growth in 6-14% of the wells
(mean, 11%) with cells with mature T lymphocyte phenotype. Two-color fluo-
rescence analysis of outgrowing cultures furthermore ascertained that these cells
had differentiated through a phase of simultaneous expression of T4 and T8
antigens and at the same time expression of the thymocyte-associated T6 anti-
gens. Thus, given the fact that 10-20% of T cell acute lymphoblastic leukemia
(T-ALLs) are CALLA', we have been able to identify a human prethymic T
lymphocyte population that might be the normal counterpart of precursor cell
to the CALLA' T-ALL cell.
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